India to United States: Melphalan Export Trade Route
India has recorded 9 verified shipments of Melphalan exported to United States, representing a combined trade value of $964.5K USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $107.2K USD. The leading Indian exporter is GLAND PHARMA LIMITED, which accounts for 50% of total export value with 1 shipments worth $479.3K USD. On the buying side, Chris Lessly is the largest importer in United States with $479.3K USD in purchases. The top 3 suppliers — GLAND PHARMA LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Melphalan corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $964.5K USD. The route is dominated by GLAND PHARMA LIMITED, which alone accounts for roughly 50% of all export value, reflecting the consolidated nature of India's melphalan manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $107.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 21.6%, placing it at rank #7 among India's top melphalan export destinations globally.
On the import side, key buyers of Indian melphalan in United States include Chris Lessly, XX RXXDY XXLABXXATOXXES XXC, DR REDDY S LABORATORIES INC and 5 others. Chris Lessly is the single largest importer with 1 shipments valued at $479.3K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#7
- Annual growth+21.6%
- Demand growth+20.2%
- Regulatory ease68/100
Top 10 Indian Melphalan Exporters to United States
Showing top 10 of 8 Indian suppliers exporting Melphalan to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLAND PHARMA LIMITED Avg $479.3K per shipment | 1 | $479.3K | 49.7% |
| 2 | DR REDDY S LABORATORIES LIMITED Avg $192.6K per shipment | 1 | $192.6K | 20.0% |
| 3 | DR REDDYS LABORATORIES LIMITED Avg $192.5K per shipment | 1 | $192.5K | 20.0% |
| 4 | AVET LIFESCIENCES PRIVATE LIMITED Avg $94.8K per shipment | 1 | $94.8K | 9.8% |
| 5 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $1.4K per shipment | 2 | $2.8K | 0.3% |
| 6 | GENETEC LIFESCIENCES Avg $1.8K per shipment | 1 | $1.8K | 0.2% |
| 7 | VEA IMPEX I PRIVATE LIMITED Avg $403 per shipment | 1 | $403 | 0.0% |
| 8 | GMSANJIVANI LLP Avg $287 per shipment | 1 | $287 | 0.0% |
This table shows the top 10 of 8 Indian companies exporting melphalan to United States, ranked by total trade value. The listed exporters are: GLAND PHARMA LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, AVET LIFESCIENCES PRIVATE LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, GENETEC LIFESCIENCES, VEA IMPEX I PRIVATE LIMITED, GMSANJIVANI LLP. GLAND PHARMA LIMITED is the dominant supplier with 1 shipments worth $479.3K USD, giving it a 50% market share. The top 3 suppliers together account for 90% of the total trade value on this route.
Top 10 Melphalan Importers in United States
Showing top 10 of 8 known buyers in United States receiving Melphalan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian melphalan in United States include Chris Lessly, XX RXXDY XXLABXXATOXXES XXC, DR REDDY S LABORATORIES INC, AVET PHARMACEUTICALS INC., JULIO MAGALLON GARCIA BRICER, among 8 total buyers. The largest importer is Chris Lessly, accounting for $479.3K USD across 1 shipments — representing 50% of all melphalan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Chris Lessly | 1 | $479.3K | 49.7% |
| 2 | XX RXXDY XXLABXXATOXXES XXC | 1 | $192.6K | 20.0% |
| 3 | DR REDDY S LABORATORIES INC | 1 | $192.5K | 20.0% |
| 4 | AVET PHARMACEUTICALS INC. | 1 | $94.8K | 9.8% |
| 5 | JULIO MAGALLON GARCIA BRICER | 2 | $2.8K | 0.3% |
| 6 | RAZON SOCIALCOYMAC SA DE CV RFC | 1 | $1.8K | 0.2% |
| 7 | To The Order of Invoice raised to | 1 | $403 | 0.0% |
| 8 | NA | 1 | $287 | 0.0% |
Top 10 Melphalan Formulations Imported by United States
Showing top 10 of 7 product formulations shipped on the India to United States Melphalan route, ranked by trade value
United States imports a wide range of melphalan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — MELPHALAN HCL FOR INJECTION 50MG/VIAL — accounts for $864.4K USD across 3 shipments. A total of 7 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MELPHALAN HCL FOR INJECTION 50MG/VIAL | 3 | $864.4K | 89.6% |
| 2 | MELPHALAN HCL FOR INJECTION 50 MG US SNBATCH NO. CP250025 MFG. DATE : FEB/2025EXP. DATE: JAN/2027 | 1 | $94.8K | 9.8% |
| 3 | MEDICINE FOR HUMAN USE MELPHALAN 50 MGBRAND NAME ALKACEL 50 MG MFG CELON PACK VAIL (HSN CODE30049049)VLS | 1 | $1.8K | 0.2% |
| 4 | Melfalax 50 Melphalan Inj | 1 | $1.5K | 0.2% |
| 5 | Melfalax 50 Melphalan Inj. | 1 | $1.3K | 0.1% |
| 6 | Contain Medicines Harmless Pharmaceutical Products Melphather 50 Mg Inj 1 Vial MELPHALAN | 1 | $403 | 0.0% |
| 7 | MELFALAX 50 - CONTENT: MELPHALAN INJECTI | 1 | $287 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 4 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's melphalan exports to United States are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GLAND PHARMA LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED — together account for 90% of total trade value on this route. The average shipment value of $107.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as melphalan hcl for injection 50 mg us snbatch no. cp250025 mfg. date : feb/2025exp. date: jan/2027 and medicine for human use melphalan 50 mgbrand name alkacel 50 mg mfg celon pack vail (hsn code30049049)vls, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, Chris Lessly is the largest importer with 1 shipments worth $479.3K USD — representing 50% of all melphalan imports from India on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $964.5K
- Avg. Shipment
- $107.2K
- Suppliers
- 8
- Buyers
- 8
- Transit (Sea)
- ~34 days
- Annual Growth
- +21.6%
Reverse Direction
United States → India — Melphalan (Import)Other Melphalan Routes
Unlock the Full India to United States Melphalan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — India to United States Melphalan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Melphalan to United States?
The leading Indian exporters of Melphalan to United States are GLAND PHARMA LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED. GLAND PHARMA LIMITED holds the largest market share at approximately 50% of total trade value on this route.
Q What is the total value of Melphalan exports from India to United States?
India exports Melphalan to United States worth approximately $964.5K USD across 9 recorded shipments. The average value per shipment is $107.2K USD.
Q Which ports does India use to ship Melphalan to United States?
The most active port of origin is SAHAR AIR with 4 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United States for Melphalan?
The average transit time for Melphalan shipments from India to United States is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Melphalan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.6% with demand growth tracking at 20.2%. The route is ranked #7 among India's top Melphalan export destinations globally.
Q How many suppliers are active on the India to United States Melphalan route?
There are currently 8 active Indian suppliers exporting Melphalan to United States. The market is moderately concentrated with GLAND PHARMA LIMITED accounting for 50% of total shipment value.
Q Who are the main importers of Melphalan from India in United States?
The leading importers of Indian Melphalan in United States include Chris Lessly, XX RXXDY XXLABXXATOXXES XXC, DR REDDY S LABORATORIES INC, AVET PHARMACEUTICALS INC., JULIO MAGALLON GARCIA BRICER. Chris Lessly is the largest buyer with 1 shipments worth $479.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Melphalan.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 8 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists